Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Recent News
Dr. Romee received his MD from Govt. Medical College Srinagar, India. He completed his postgraduate training and hematology and oncology fellowship at University of Minnesota where he also did his post-doctoral training in Dr. Jeffrey S. Miller’s laboratory. Afterward, he did an advanced bone marrow transplant fellowship at Washington University in Saint Louis where he stayed on as faculty before moving to Dana-Farber Cancer Institute.
VIDEO:
Rizwan Romee, MD, director of Dana-Farber’s Haploidentical Donor Transplant Program, discusses immunotherapy treatment options for advanced hematologic malignancies. Dr. Romee’s clinical focus includes advanced myeloid malignancies and NK cell based cellular therapy. Learn more about the Hematologic Oncology at Dana-Farber: http://www.dana-farber.org/hematologic-oncology-treatment-center/
Dana-Farber Cancer Institute450 Brookline AvenueBoston, MA 02215Get Directions